0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Clusterin

Clusterin

Brief Information

Name:Clusterin
Target Synonym:Epididymis Secretory Sperm Binding Protein,CLI,Apolipoprotein J,ApoJbeta,Complement cytolysis inhibitor a chain,Testosterone-repressed prostate message 2,Complement cytolysis inhibitor b chain,ApoJalpha,AAG4,Complement cytolysis inhibitor,NA1/NA2,APOJ,CLU
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CLU-H5227 Human Human Clusterin / CLUS Protein, His Tag
CLU-H5227-structure
CLU-H5227-sds

Synonym Name

CLU,Clusterin,AAG4,APOJ,CLI,KUB1,SGP-2,SP-40,TRPM2

Background

Clusterin (CLU) is also known as dimeric acidic glycoprotein (DAG protein), testosterone repressed prostate message-2 (TRPM-2), sulfated glycoprotein-2 (SGP-2) and complement lysis inhibitor (CLI), is a secreted multifunctional glycoprotein protein which belongs to the clusterin family. Intracellular cleavages of the precursor of clusterin remove the signal peptide and generate comparably sized ¦Á and ¦Â chains which are secreted as an 80 kDa N

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
AB-16B5 16B5; AB-16B5; AB-sCLU mAB Phase 2 Clinical National Research Council Biotechnology Research Institute Solid tumours; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis Details

This web search service is supported by Google Inc.

totop